BioCryst Pharmaceuticals, Inc. (BCRX)

Last Closing Price: 8.50 (2026-03-05)

Expense Ratio (Annual)

Expense Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The expense ratio is calculated by taking the operating expenses and then dividing them by earned premium. Calculated as: (Total Operating Expenses - Underwriting Losses Total) / Net Premiums Earned

BioCryst Pharmaceuticals, Inc. (BCRX) Expense Ratio data is not available.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$874.84M
$263.86M
$19.07M
$855.76M
$533.85M
$340.99M
$-73.60M
$267.39M
$267.39M
$263.86M
$263.86M
$263.86M
$263.86M
$340.99M
$338.05M
209.89M
218.58M
$1.26
$1.21
Balance Sheet Financials
$404.35M
$8.78M
$109.81M
$514.16M
$196.07M
$428.67M
$437.25M
$633.31M
$-119.15M
$-119.15M
$-119.15M
213.06M
Cash Flow Statement Financials
$347.37M
$-13.69M
$-349.93M
$106.32M
$91.34M
$-14.99M
$85.07M
--
--
Fundamental Metrics & Ratios
2.06
--
--
1.39
-4.05
97.82%
38.98%
38.98%
38.64%
30.56%
30.16%
$345.45M
--
Expense Ratio
--
--
1.70
3.53
8.19
44.57
-221.45%
-221.45%
51.32%
85.25%
$-0.56
$1.58
$1.59